USP14 Gene Expression Combined with Clinical Factors for Predicting Symptomatic Recurrence After Surgery for Deep Infiltrating Endometriosis: A Retrospective Cohort Study

Observational OA: closed public-domain-us
View on OpenAlex View on PubMed View at publisher

Abstract

Deep infiltrating endometriosis (DIE) exhibits high postoperative recurrence rates, yet current prediction models lack molecular insights for precise risk stratification. This study aimed to determine whether ubiquitin-specific protease 14 (USP14) mRNA expression in DIE lesions is independently associated with postoperative symptomatic recurrence and to construct a combined clinico-molecular predictive model with enhanced accuracy. A retrospective cohort of 235 surgically treated DIE patients was analyzed. The least absolute shrinkage and selection operator (LASSO) was applied for variable selection. Subsequently, Cox multivariate regression was performed to identify independent risk factors. Multivariate Cox regression revealed that high USP14 expression (HR = 1.656; 95% CI: 1.307-2.099; P < 0.001), adhesion (HR = 1.861; 95%CI: 1.013-3.419; P = 0.045), bowel lesions (HR = 2.168; 95%CI: 1.278-3.679; P = 0.004), and adenomyosis (HR = 2.645; 95%CI: 1.568-4.462; P < 0.001) were independent risk factors, while GnRH-a therapy ≥ 6 months (HR = 0.126; 95%CI: 0.044-0.363; P < 0.001) and postoperative pregnancy (HR = 0.402; 95%CI: 0.200-0.807; P = 0.010) were independent protectors. The combined model integrating USP14 with these clinical factors achieved a superior C-index of 0.896 (95%CI: 0.879-0.912), outperforming the clinical-only model [C-index: 0.870 (95%CI: 0.849-0.892)]. Bootstrap internal validation (2,000 resamples) yielded optimism-corrected C-indices of 0.888 and 0.863 for the combined and clinical-only models, respectively. The integrated discrimination improvement (IDI) was 0.044 (95% CI: -0.013 to 0.11; P = 0.047); as the bootstrap confidence interval narrowly included zero, this result was interpreted as borderline, while complementary analyses supported the incremental value of USP14 (continuous net reclassification improvement: 0.655, P = 0.026; bootstrap-validated ΔC-index: 0.020, 95% CI: 0.002-0.048, P = 0.033). In conclusion, high USP14 expression is independently associated with postoperative symptomatic recurrence in DIE, and its incorporation into a combined prediction model provides a modest but consistent improvement in prognostic accuracy; as a retrospectively developed, internally validated model, it is hypothesis-generating and requires external, multi-center validation before clinical implementation.

My notes (saved in your browser only)

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (34)

Source provenance

europepmc
last seen: 2026-11-20T06:18:20.042577+00:00
openalex
last seen: 2026-11-20T06:09:37.170340+00:00
pubmed
last seen: 2026-11-20T06:11:28.355738+00:00
unpaywall
last seen: 2026-11-20T08:37:33.920708+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine